New Horizon Medical Solutions has announced a strategic collaboration with Soring, the U.S. affiliate of German medical technology company Söring, to distribute an ultrasonic wound debridement system designed to enhance wound care treatment. The partnership aims to address critical gaps in wound management by combining NHMS's expertise in advanced wound care with Söring's specialized ultrasonic technology.
The Söring Ultrasonic-Assisted Wound debridement system consists of an ultrasonic generator and instrument intended for debridement and wound cleansing of chronic and acute wounds. The technology can remove fibrin tissues including necroses, fibrin, scab, and pus while breaking up biofilms that impede healing. Clinical applications include treatment of diabetic foot syndrome, decubitus ulcers, burns, post-surgical wounds, and post-traumatic wounds.
Jeffrey Alan Niezgoda, MD, Chief Medical Officer of Kent Imaging and board member of NHMS, emphasized the potential impact of integrating this technology with existing diagnostic tools. "The use of SONOCA 185 and the UAW instruments for Ultrasonic Wound Debridement guided by SnapshotGLO and monitored by SnapshotNIR can significantly improve wound management and lead to better patient outcomes," Niezgoda stated. He noted these devices synergistically optimize wound bed preparation prior to the application of cellular and/or tissue-based products.
Will Hall, CEO of New Horizon Medical Solutions, explained the strategic rationale behind the collaboration. "This collaboration reflects our belief that the future of wound care lies in combining advanced technology with evidence-based clinical solutions," Hall said. "By bringing Söring's ultrasonic system into our portfolio, we're expanding access to innovative tools that address critical gaps in treatment while improving efficiency and outcomes across care settings."
The partnership represents a significant development in wound care technology integration, potentially affecting millions of patients suffering from chronic wounds. According to industry data, chronic wounds affect approximately 6.5 million patients in the United States alone, with treatment costs exceeding $25 billion annually. The ultrasonic debridement technology could offer healthcare providers a more efficient method for wound bed preparation, which is critical for successful healing outcomes.
Söring, founded in 1985 and headquartered in Germany, specializes in ultrasonic tissue resection and ablation technologies used by healthcare professionals worldwide. The company focuses on making surgical procedures more efficient, safer, and easier to perform through intuitive user experience and direct service support. More information about the companies can be found at https://www.nhmedical.com.
The collaboration between NHMS and Soring could potentially transform wound care protocols in hospitals, wound care centers, and outpatient facilities by providing clinicians with advanced tools for debridement procedures. As healthcare systems continue to seek more effective treatments for complex wounds, this partnership represents a step toward integrating multiple technologies to address the multifaceted challenges of wound healing.
